【Introduction】
Product Name: Human RSV-F Antibody (Palivizumab, Research Use)
Catalog Number: NBR-0962
Target Name: RSV-F
Trade Name: Palivizumab
Antibody Drug Description: Palivizumab (Synagi) is a humanized monoclonal antibody that provides immunoprophylaxis against serious lower respiratory tract infections (LRTIs) caused by respiratory syncytial virus (RSV).
【Description】
Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS:N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG
【Gene Information】
Gene Name: RSV-F
Synonyms:
Target Description:
Ensembl:
Uniprot: